Search Browse Earnings

Aspira Women's Health Inc. — SlamSEC

Aspira Women's Health Inc.

OTC:AWHL

In Vitro & In Vivo Diagnostic Substances·AUSTIN, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$9.2M

FY 2024

Adj. EBITDA

-$18.6M

-203.1% margin

FY 2024

Net Income

-$16.7M

-182.3% margin

FY 2024

EPS (Diluted)

-$1.81

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$2.6M

FY 2024

Total Debt

$2.1M

FY 2024

Net Cash

$497,000

FY 2024

Enterprise Value

—

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

—

Employees

—